Skip to main content.

Opioid

Picture of Francie Diep
If you were to seek opioid addiction treatment for yourself or a loved one, what are the chances you'd run into a facility that didn’t offer the best possible treatment?
Picture of Kellie  Schmitt
Author and physician Sunita Puri talks to journalist Fran Smith about why journalists should be telling these stories — and how they can do so in a more thoughtful way.
Picture of Kellie  Schmitt
Only about 6 percent of medical practitioners have obtained a government waiver that allows them to prescribe a crucial drug for treating opioid addiction. Here's why that's a problem.
Picture of William Heisel
Recent stories from the New York Times and the Washington Post encapsulate why language choices are so important for responsible reporting on addiction.
Picture of Martha Rosenberg

Drug companies have "bought" opioid favorable guidelines and the FDA continues to approve new opioids. Don't blame patients for the opioid abuse epidemic

Picture of a c
By a c

Reporting on Health Contributing Editor William Heisel set off a spirited discussion this week on Twitter on the risk of addiction to opioid pain medicine. What are the implications for chronic pain management and treatment?

Picture of William Heisel

Dr. Andrew Kolodny, the chief medical officer for the Phoenix House discusses evidence-based addiction treatment and the risk of addiction among patients treated with opioids.

Picture of William Heisel

Dr. Andrew Kolodny is the Chief Medical Officer and Senior Vice President at Phoenix House Foundation in New York. He’s also a go-to source for journalists looking for perspective on the nation’s prescription drug abuse problem.

Picture of Julia Landau

At the center of one of the great medical controversies of our time, the mishmash around pain medication and addiction to prescription drugs has caused alarm in law enforcement and the public.  But the realities of patients who have chronic pain problems, chronic addiction problems, or both, are not

Announcements

Do the competing bills put forward by House Speaker Nancy Pelosi and Sens. Charles Grassley and Ron Wyden have a chance of becoming law? This webinar will give an overview of the proposals and weigh in on the future of the battle to curb soaring drug prices. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth